Standard Family Office’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Standard Family Office's EXAS Position: Q4 2022 in Review
Standard Family Office sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 24 shares — an estimated $1K sold.
Standard Family Office first reported a position in EXAS in Q4 2020 and held it in 6 quarters. The position peaked at $18K in Q2 2021. 552 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.
- Standard Family Office reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
- Standard Family Office sold 24 Exact Sciences shares in Q4 2022, an estimated $1K.
- Standard Family Office first reported a position in Exact Sciences in Q4 2020 and held it in 6 quarters.
- Standard Family Office's Exact Sciences position peaked at $18K in Q2 2021.
- 552 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.
Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.